In this study, we demonstrated for the first time that the IL-33/ST2 signaling pathway plays an important role in regulating LPIN1 expression, by enhancing the association of the c-Jun transcription factor with the LPIN1 promoter in breast cancer cells. This evidence concerns the gene IL33 and breast cancer.